Scheduling a proper dose of anti-angiogenic drugs that block these pro-angiogenic proteins or their receptors, such as VEGF/VEGFR, could help restore functional vessels, thus alleviating tumor hypoxia (137). This evidence concerns the gene VEGFA and neoplasm.